Semax and high-stim pre-workouts: separating hype from data

What did @armonadibi actually say?

The creator compared two compounds used for growth hormone stimulation and came down firmly on one side. He said CJC-1295 "raises your natural growth hormone levels" but argued that MK-677, which he sells under the brand name "ceramax," "heals injuries better" and "puts a little more size and water inside the muscle." He also pitched the pill format as a practical advantage over injecting CJC-1295. Then he disclosed, almost in passing, that ceramax is "our top seller."

That last part matters. This is a creator recommending a product he profits from, and the comparison is structured entirely to favor his product. That framing should be the first thing you notice, not the last.

Does the science back this up?

Partially, but with significant gaps. The claim that MK-677 outperforms CJC-1295 for injury healing is not supported by head-to-head human trial data. Both compounds stimulate growth hormone through completely different mechanisms, and no published clinical trial has directly compared their effects on tissue repair.

MK-677 (ibutamoren) is a ghrelin receptor agonist that stimulates GH secretion orally. It has been studied in humans. Nuttall et al. (1999, Journal of Clinical Endocrinology and Metabolism) found it increased IGF-1 and lean body mass in older adults. Svensson et al. (1998, same journal) showed sustained GH elevation over 12 months. These are real findings, but they involved clinical populations, not healthy athletes seeking injury recovery.

CJC-1295 is a GHRH analog. It has far less published human data. Most CJC-1295 research is in animals or small phase I/II trials. Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism) showed CJC-1295 increased GH and IGF-1 levels in healthy adults, but injury healing was not studied.

The claim that MK-677 heals injuries better than CJC-1295 is not something the current literature can confirm or deny directly. Saying it does is speculation dressed as coaching experience.

What did they get wrong (or right)?

They got the basic mechanism right: CJC-1295 does raise GH levels by mimicking growth hormone releasing hormone. That is accurate. MK-677 does cause measurable increases in IGF-1 and lean mass in some studied populations. The oral bioavailability point is real. MK-677 does not require injection, which is a legitimate practical difference.

What they got wrong is more consequential. Saying MK-677 "heals injuries better" is an unverifiable therapeutic claim. The FDA has not approved either compound for this purpose. MK-677 is not a licensed drug in the U.S. for injury recovery. The creator is also selling the product he is recommending, which is a financial conflict of interest that goes unacknowledged in the video.

The water retention point deserves scrutiny too. MK-677 is well-documented to increase water retention and can cause peripheral edema, increased appetite, and elevated fasting glucose, especially at higher doses. Framing water inside the muscle as a pure benefit without mentioning these trade-offs is incomplete at best.

What should you actually know?

Neither MK-677 nor CJC-1295 is FDA-approved for the uses being discussed here. Both are sold as research chemicals or through compounding pharmacies under specific legal frameworks. If you are considering either compound, that regulatory status matters for both safety and legal reasons.

MK-677 has the most human data of the two, which is worth acknowledging. But the studies involve specific populations and clinical oversight. The side effect profile includes elevated blood glucose, increased cortisol in some users, and significant water retention. Nass et al. (2008, Annals of Internal Medicine) found MK-677 increased lean mass in older adults but also raised fasting glucose and HbA1c, raising concerns for metabolic health.

CJC-1295 has less human safety data, not more. Fewer published trials mean fewer known risks, not fewer actual risks. Anyone presenting the injectable format as the only meaningful downside of CJC-1295 is leaving out a lot.

If you are working with a healthcare provider on GH optimization or recovery, these compounds may be part of a legitimate conversation. But taking product recommendations from someone who profits from the sale, without disclosing the conflict clearly, is not a substitute for clinical guidance.